STOCKHOLDERS’ AGREEMENTStockholders’ Agreement • April 2nd, 2015 • Sacks Bradley J. • Pharmaceutical preparations • New York
THIS STOCKHOLDERS’ AGREEMENT is made as of the 31st day of January, 2014 by and among Michael Sacks (“Sacks”), The Punch Trust (“TPT”) and IPMD GmbH, an Austrian limited liability company (“IPMD” and, collectively, with Sacks and TPT, the “Investors”).
ASSIGNMENT AGREEMENTAssignment Agreement • April 2nd, 2015 • Sacks Bradley J. • Pharmaceutical preparations • New York
This Assignment Agreement (this “Agreement”) is made as of January 31, 2014 (the “Effective Date”) by and among Michael Sacks (“Sacks”), The Punch Trust (“TPT” and together with Sacks, the “Assignees”), and IPMD GmbH, an Austrian limited liability company (the “Assignor”). The Assignor and the Assignees are referred to collectively in this agreement as the “parties.”
EQUALIZATION AGREEMENTEqualization Agreement • April 2nd, 2015 • Sacks Bradley J. • Pharmaceutical preparations • New York
THIS EQUALIZATION AGREEMENT (this “Agreement”) is made as of the 31st day of January, 2014 by and among Michael Sacks (“Sacks”), The Punch Trust (“TPT” and, together with Sacks, the “Investors”), Melmed Holdings AG, a company incorporated in Switzerland (“Melmed”), and IPMD GmbH, an Austrian limited liability company (“IPMD”). The Investors, Melmed and IPMD are referred to collectively in this Agreement as the “parties.”
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 2nd, 2015 • Sacks Bradley J. • Pharmaceutical preparations • New York
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of the 31st day of January, 2014, by and among ULURU Inc., a Nevada corporation (the “Company”), Michael Sacks (“Sacks”) and The Punch Trust (“TPT,” and together with Sacks and any party added to this Agreement pursuant to Section 3.13, the “Investors”).
IMPLEMENTATION AGREEMENTImplementation Agreement • April 2nd, 2015 • Sacks Bradley J. • Pharmaceutical preparations • New York
This Implementation Agreement (this “Agreement”) is made as of January 31, 2014 (the “Effective Date”) by and among Michael Sacks (“Sacks”), The Punch Trust (“TPT,” and together with Sacks, the “Holders”), IPMD GmbH, an Austrian limited liability company (the “Assignor”), and ULURU Inc., a Nevada corporation (the “Company”). The Company, the Assignor and the Holders are referred to collectively in this agreement as the “parties.”
FIRST AMENDMENT TO VOTING AGREEMENTVoting Agreement • April 13th, 2017 • Sacks Bradley J. • Pharmaceutical preparations • New York
THIS FIRST AMENDMENT TO VOTING AGREEMENT (this “First Amendment”), is made and entered into as of this 31st day of March, 2017, by and among ULURU, Inc., a Nevada corporation (the “Company”), each holder of the Company’s Series B Convertible Preferred Stock, $0.001 par value per share listed on Schedule A to the Voting Agreement (together with any subsequent transferees, who become parties to the Voting Agreement as “Investors” pursuant to Subsection 5.1 of the Voting Agreement, the “Investors”), and those certain stockholders of the Company listed on Schedule B to the Voting Agreement (the “Key Holders,” and together collectively with the Investors, the “Stockholders”). Capitalized terms used herein shall have the meaning given such terms in the Voting Agreement.
ULURU INC. STOCK PURCHASE AGREEMENTStock Purchase Agreement • April 4th, 2016 • Sacks Bradley J. • Pharmaceutical preparations • Nevada
THIS STOCK PURCHASE AGREEMENT (the “Agreement”) is made and entered into as March 29, 2016 by and between ULURU Inc., a Nevada corporation (the “Company”), and the investors who have executed a counterpart signature page to this Agreement (each, “Investor”; collectively, the “Investors”). For convenience, the Investors are identified on Exhibit A.
JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)Joint Filing Agreement • April 2nd, 2015 • Sacks Bradley J. • Pharmaceutical preparations
The undersigned acknowledge and agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13D may be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained herein or therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.
JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)Joint Filing Agreement • July 29th, 2015 • Sacks Bradley J. • Pharmaceutical preparations
The undersigned acknowledge and agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13D may be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained herein or therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.
ULURU INC. NOTE, WARRANT, AND PREFERRED STOCK PURCHASE AGREEMENTNote, Warrant, and Preferred Stock Purchase Agreement • March 2nd, 2017 • Sacks Bradley J. • Pharmaceutical preparations • New York
THIS NOTE, WARRANT, AND PREFERRED STOCK PURCHASE AGREEMENT (this “Agreement”), is made as of the 27th day of February, 2017 by and among ULURU Inc., a Nevada corporation (the “Company”), Velocitas Partners, LLC, a Delaware limited liability company (“Velocitas”), and the investors listed on Exhibit A attached to this Agreement (each a “Purchaser” and together with Velocitas, the “Purchasers”).
Michael SacksSacks Bradley J. • April 2nd, 2015 • Pharmaceutical preparations
Michael I. SacksSacks Bradley J. • March 2nd, 2017 • Pharmaceutical preparations
